SPONSOR
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Total Trials
17
Recruiting
17
Phases
Phase 2, Phase 3, Phase 1, Phase 2, Phase 3, Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: HypophosphatemiaGastric Junction AdenocarcinomaGastric CancerImmunotherapyNeoadjuvant TherapiesAdvanced MalignanciesPrimary Immune ThrombocytopeniaPancreatic CancerLocally Advanced Cervical CarcinomaFemoral Neck Fractures
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Hypophosphatemia, Gastric Junction Adenocarcinoma, Gastric Cancer, Immunotherapy.
The trial portfolio spans Phase 2, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
How many clinical trials has Union Hospital, Tongji Medical College, Huazhong University of Science and Technology sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, of which 17 are actively recruiting participants. These trials cover conditions including Hypophosphatemia, Gastric Junction Adenocarcinoma, Gastric Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Union Hospital, Tongji Medical College, Huazhong University of Science and Technology research focus on?
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trials span Hypophosphatemia, Gastric Junction Adenocarcinoma, Gastric Cancer, Immunotherapy, Neoadjuvant Therapies, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Union Hospital, Tongji Medical College, Huazhong University of Science and Technology clinical trial?
To participate in a Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials with current recruitment status updated daily.
Clinical Trials by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NCT07233889
Recruiting
Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.
Hypophosphatemia
NCT06826079 Phase 2, Phase 3
Recruiting
Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
Gastric Junction Adenocarcinoma
NCT06717880 Phase 1
Recruiting
A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
Advanced Malignancies
NCT06686927 Phase 2
Recruiting
Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP
Primary Immune Thrombocytopenia
NCT06491472 Phase 2
Recruiting
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
Pancreatic Cancer
NCT07400536 Phase 3
Recruiting
A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT
Locally Advanced Cervical Carcinoma
NCT06937138
Recruiting
Artificial Intelligence-Assisted vs Surgeon-Planned Trajectories in Freehand Femoral Neck Screw Fixation
Femoral Neck Fractures
NCT05445011 Phase 1
Recruiting
Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
NCT06735495 Phase 1, Phase 2
Recruiting
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
B-Cell Lymphoblastic Leukemia/Lymphoma
NCT07547735 Phase 2
Recruiting
Phase II Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis
Knee Osteoarthritis
NCT06490211
Recruiting
The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
Urinary System Carcinoma
NCT07355972 EARLY_Phase 1
Recruiting
Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
SSc-Systemic Sclerosis
NCT06691685 EARLY_Phase 1
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
Multiple Myeloma
NCT06140966 Phase 2
Recruiting
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Multiple Myeloma
NCT06654011 Phase 2
Recruiting
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
Cervical Adenocarcinoma
NCT05731427
Recruiting
Research on the Mechanism Affecting Progression of Bronchiectasis
Bronchiectasis
NCT06653478
Recruiting
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
Artificial Intelligence
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology